To evaluate if Ab-T1 treatment inhibits pTau spreading, hTau transgenic mice were stereotactically injected with pathological tau from human brains with Alzheimer’s disease, 9 females (3 groups of n = 3). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.